A protocol for scoping reviews on the role of whole-body and dedicated body-part magnetic resonance imaging for assessment of adult and juvenile idiopathic inflammatory myopathies.

Assessment Damage Idiopathic inflammatory myopathy Magnetic resonance imaging Myositis

Journal

Rheumatology international
ISSN: 1437-160X
Titre abrégé: Rheumatol Int
Pays: Germany
ID NLM: 8206885

Informations de publication

Date de publication:
08 Jul 2024
Historique:
received: 22 04 2024
accepted: 08 06 2024
medline: 8 7 2024
pubmed: 8 7 2024
entrez: 8 7 2024
Statut: aheadofprint

Résumé

Currently, standardized magnetic resonance imaging (MRI) scoring systems and protocols for assessment of idiopathic inflammatory myopathies (IIMs) in children and adults are lacking. Therefore, we will perform a scoping review of the literature to collate and evaluate the existing semi-quantitative and quantitative MRI scoring systems and protocols for the assessment and monitoring of skeletal muscle involvement in patients with IIMs. The aim is to compile evidence-based information that will facilitate the future development of a universal standardized MRI scoring system for both research and clinical applications in IIM. A systematic search of electronic databases (PubMed, EMBASE, and Cochrane) will be undertaken to identify relevant articles published between January 2000 and October 2023. Data will be synthesized narratively. This scoping review seeks to comprehensively summarize and evaluate the evidence on the scanning protocols and scoring systems used in the assessment of diagnosis, disease activity, and damage using skeletal muscle MRI in IIMs. The results will allow the development of consensus recommendations for clinical practice and enable the standardization of research methods for the MRI assessment of skeletal muscle changes in patients with IIMs.

Identifiants

pubmed: 38976028
doi: 10.1007/s00296-024-05649-7
pii: 10.1007/s00296-024-05649-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIEHS NIH HHS
ID : ES101081
Pays : United States
Organisme : NIEHS NIH HHS
ID : ES101081
Pays : United States

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, Visser M, Alfredsson L, Amato AA, Barohn RJ, Liang MH, Singh JA, Aggarwal R, Arnardottir S, Chinoy H, Cooper RG, Dankó K, Dimachkie MM, Feldman BM, Torre IG, Gordon P, Hayashi T, Katz JD, Kohsaka H, Lachenbruch PA, Lang BA, Li Y, Oddis CV, Olesinska M, Reed AM, Rutkowska-Sak L, Sanner H, Selva-O’Callaghan A, Song YW, Vencovsky J, Ytterberg SR, Miller FW, Rider LG, UK and Ireland) (2017) International Myositis Classification Criteria Project consortium, The Euromyositis register and The Juvenile Dermatomyositis Cohort Biomarker Study and Repository (JDRG) (. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76(12):1955–1964. https://doi.org/10.1136/annrheumdis-2017-211468
Lundberg IE, Fujimoto M, Vencovsky J, Aggarwal R, Holmqvist M, Christopher-Stine L, Mammen AL, Miller FW (2021) Idiopathic inflammatory myopathies. Nat Rev Dis Primers 7(1):86. https://doi.org/10.1038/s41572-021-00321-x
doi: 10.1038/s41572-021-00321-x pubmed: 34857798
Cavagna L, Trallero-Araguás E, Meloni F, Cavazzana I, Rojas-Serrano J, Feist E, Zanframundo G, Morandi V, Meyer A, Pereira da Silva JA, Matos Costa CJ, Molberg O, Andersson H, Codullo V, Mosca M, Barsotti S, Neri R, Scirè C, Govoni M, Furini F, Lopez-Longo FJ, Martinez-Barrio J, Schneider U, Lorenz HM, Doria A, Ghirardello A, Ortego-Centeno N, Confalonieri M, Tomietto P, Pipitone N, Rodriguez Cambron AB, Blázquez Cañamero MÁ, Voll RE, Wendel S, Scarpato S, Maurier F, Limonta M, Colombelli P, Giannini M, Geny B, Arrigoni E, Bravi E, Migliorini P, Mathieu A, Piga M, Drott U, Delbrueck C, Bauhammer J, Cagnotto G, Vancheri C, Sambataro G, De Langhe E, Sainaghi PP, Monti C, Gigli Berzolari F, Romano M, Bonella F, Specker C, Schwarting A, Villa Blanco I, Selmi C, Ceribelli A, Nuno L, Mera-Varela A, Perez Gomez N, Fusaro E, Parisi S, Sinigaglia L, Del Papa N, Benucci M, Cimmino MA, Riccieri V, Conti F, Sebastiani GD, Iuliano A, Emmi G, Cammelli D, Sebastiani M, Manfredi A, Bachiller-Corral J, Sifuentes Giraldo WA, Paolazzi G, Saketkoo LA, Giorgi R, Salaffi F, Cifrian J, Caporali R, Locatelli F, Marchioni E, Pesci A, Dei G, Pozzi MR, Claudia L, Distler J, Knitza J, Schett G, Iannone F, Fornaro M, Franceschini F, Quartuccio L, Gerli R, Bartoloni E, Bellando Randone S, Zampogna G, Gonzalez Perez MI, Mejia M, Vicente E, Triantafyllias K, Lopez-Mejias R, Matucci-Cerinic M, Selva-O’, Callaghan A, Castañeda S, Montecucco C, Gonzalez-Gay MA (2019) Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course. J Clin Med 8(11):2013. https://doi.org/10.3390/jcm8112013
Zubair AS, Salam S, Dimachkie MM, Machado PM, Bhaskar R (2023) Imaging biomarkers in the idiopathic inflammatory myopathies. Front Neurol 14:1146015. https://doi.org/10.3389/fneur.2023.1146015
doi: 10.3389/fneur.2023.1146015 pubmed: 37181575 pmcid: 10166883
Theodorou DJ, Theodorou SJ, Kakitsubata Y (2012) Skeletal muscle disease: patterns of MRI appearances. Br J Radiol 85(1020):e1298–1308. https://doi.org/10.1259/bjr/14063641
doi: 10.1259/bjr/14063641 pubmed: 22960244 pmcid: 3611737
Feinstein AR, Wells CK, Joyce CM, Josephy BR (1985) The evaluation of sensibility and the role of patient collaboration in clinimetric indexes. Trans Assoc Am Physicians 98:146–149
pubmed: 3916037
Hebert JS, Wolfe DL, Miller WC, Deathe AB, Devlin M, Pallaveshi L (2009) Outcome measures in amputation rehabilitation: ICF body functions. Disabil Rehabil 31(19):1541–1554. https://doi.org/10.1080/09638280802639467
doi: 10.1080/09638280802639467 pubmed: 19479495
Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, Hempel S, Akl EA, Chang C, McGowan J, Stewart L, Hartling L, Aldcroft A, Wilson MG, Garritty C, Lewin S, Godfrey CM, Macdonald MT, Langlois EV, Soares-Weiser K, Moriarty J, Clifford T, Tunçalp Ö, Straus SE (2018) PRISMA Extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Ann Intern Med 169(7):467–463. https://doi.org/10.7326/M18-0850
doi: 10.7326/M18-0850 pubmed: 30178033
Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. Part 1. N Engl J Med 292(7):344–347. https://doi.org/10.1056/NEJM197502132920706
doi: 10.1056/NEJM197502132920706 pubmed: 1090839
Chan MW, Leckie A, Xavier F, Uleryk E, Tadros S, Blanchette V, Doria AS (2013) A systematic review of MR imaging as a tool for evaluating haemophilic arthropathy in children. Haemophilia 19(6):e324–e334. https://doi.org/10.1111/hae.12248
doi: 10.1111/hae.12248 pubmed: 23919318
Tolsgaard MG, Ellaway R, Woods N, Norman G (2019) Salami-slicing and plagiarism: how should we respond? Adv Health Sci Educ Theory Pract 24(1):3–14. https://doi.org/10.1007/s10459-019-09876-7
doi: 10.1007/s10459-019-09876-7 pubmed: 30756257
Goyal NA, Mozaffar T, Dimackie MM (2023) Imaging beyond muscle resonance imaging in inclusion body myositis. Clin Exp Rheumatol 41(2):386–392. https://doi.org/10.55563/clinexprheumatol/uimkey
doi: 10.55563/clinexprheumatol/uimkey pubmed: 36700664
Day J, Patel S, Limaye V (2017) The role of magnetic resonance imaging techniques in evaluation and management of the idiopathic inflammatory myopathies. Semin Arthritis Rheum 46(5):642–649. https://doi.org/10.1016/j.semarthrit.2016.11.001
doi: 10.1016/j.semarthrit.2016.11.001 pubmed: 28088340

Auteurs

Mickael Essouma (M)

Network of Immunity in Infection, Malignancy and Autoimmunity, Universal Scientific Education and Research Network, Yaounde, Cameroon.

Daniel Brito de Araujo (DB)

Internal Medicine Department, Universidade Federal de Pelotas, Pelotas, Rio Grande do Sul, RS, Brazil. araujodb@gmail.com.
Department of Internal Medicine, Faculdade de Medicina, Universidade Federal de Pelotas, Rua Santos Dumont, 172 / 703. 96.020-380, Pelotas, Rio Grande do Sul (RS), Brazil. araujodb@gmail.com.

Jessica Day (J)

The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
Royal Melbourne Hospital, Melbourne, VIC, Australia.
The University of Melbourne, Melbourne, VIC, Australia.

Edoardo Conticini (E)

Rheumatology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.

Mary Anne Riopel (MA)

Moravian College, Bethlehem, PA, USA.

Adriana Maluf Elias (AM)

Pediatric Rheumatology Unit, Children's Institute, Faculdade de Medicina, Hospital das Clínicas HCFMUSP, Universidade de São Paulo, São Paulo, SP, Brazil.

Vitor Tavares Paula (VT)

Radiology Department, Children's Institute, Faculdade de Medicina, Hospital das Clínicas HCFMUSP, Universidade de São Paulo, São Paulo, SP, Brazil.

Clarissa Harumi Omori (CH)

Pediatric Rheumatology Unit, Children's Institute, Faculdade de Medicina, Hospital das Clínicas HCFMUSP, Universidade de São Paulo, São Paulo, SP, Brazil.

Julio Brandão Guimarães (JB)

Grupo Fleury Medicina e Saúde, Universidade Federal de São Paulo, EPM-UNIFESP, São Paulo, Brazil.

Daren Gibson (D)

Medical Imaging, Fiona Stanley Hospital, Murdoch, Daren, Australia.

Claudia Saad-Magalhaes (C)

Pediatric Rheumatology Unit, Department of Pathology, Botucatu Medical School, São Paulo State University, Botucatu, São Paulo, Brazil.

Simone Appenzeller (S)

Department of Orthopedics, Rheumatology and Traumatology, University of Campinas, Campinas, SP, Brazil.

Adam Schiffenbauer (A)

Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, USA.

Pedro M Machado (PM)

Department of Neuromuscular Diseases and Centre for Rheumatology, Department of Rheumatology and Queen Square Centre for Neuromuscular Diseases, University College London, University College London Hospitals NHS Foundation Trust, London, UK.

Brian M Feldman (BM)

Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada.

Julie J Paik (JJ)

Department of Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Lisa Christopher-Stine (L)

Department of Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Lisa G Rider (LG)

Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, USA.

Ann Reed (A)

Department of Pediatrics, Division of Pediatric Rheumatology, Duke University, Durham, NC, USA.

Anneke J van der Kooi (AJ)

Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, Netherlands.

Edoardo Marrani (E)

Rheumatology Unit, ERN-ReCONNET Center, Meyer Children's Hospital IRCCS, Florence, Italy.

Elie Naddaf (E)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Eva Kirkhus (E)

Department of Radiology, Oslo University Hospital, Oslo, Norway.

Helga Sanner (H)

Department of Rheumatology, Oslo University Hospital, Oslo, Norway.
Department of Health Sciences, Oslo New University College, Oslo, Norway.

Iazsmin Bauer-Ventura (I)

Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL, USA.

James B Lilleker (JB)

Division of Musculoskeletal and Dermatological Sciences, Centre for Musculoskeletal Research, School of Biological Sciences, University of Manchester, Manchester, UK.
Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

Latika Gupta (L)

Division of Musculoskeletal and Dermatological Sciences, Centre for Musculoskeletal Research, School of Biological Sciences, University of Manchester, Manchester, UK.
Department of Rheumatology, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, UK.

Matteo Lucchini (M)

UOC Neurologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Dipartimento di Neuroscienze, Sezione di Neurologia, Catholic University of Sacred Heart, Rome, Italy.

Mazen M Dimachkie (MM)

Department of Neurology, University of Kansas, Kansas City, KS, USA.

Mirkamal Tolend (M)

Department of Diagnostic Imaging, Research Institute, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.

Tamima Mohamad Abou Arabi (TMA)

Pediatric Rheumatology Unit, Children's Institute, Faculdade de Medicina, Hospital das Clínicas HCFMUSP, Universidade de São Paulo, São Paulo, SP, Brazil.

Siamak Moghadam-Kia (S)

Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Susan O'Hanlon (S)

The South Metropolitan Health Service of Western Australia, Murdoch, Australia.

Susan Phaneuf (S)

Patient representative, Putnam, USA.

Samuel Katsuyuki Shinjo (SK)

Division of Rheumatology, Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo, Brazil.

Andrea Schwarz Doria (AS)

Department of Diagnostic Imaging, Research Institute, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.

Classifications MeSH